Clinical Trial Update: Two Stage Study of Combination of Chemotherapy, SHR-1210 and/or Decitabine for Relapsed/Refractory PMBCLs [Phase 1, Phase 2]

View source ↗

Summary

A two-stage Phase 1/2 trial evaluating chemotherapy in combination with SHR-1210 (a PD-1 inhibitor) and/or decitabine for relapsed/refractory primary mediastina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mediastinal Large B-cell Lymphoma

Drugs mentioned

• SHR-1210 (camrelizumab)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Primary Mediastinal Large B-cell Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN